Atlas Trials

Comparison of Keloid Volume and Symptoms Reduction Between Intralesional Umbilical-Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide Injection as Keloid Therapy: A Randomised Controlled Trial

Clinical trial NCT05887804 · COMPLETED

Trial details

NCT number
NCT05887804
Sponsor
Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
KeloidStem Cell
Start date
2021-10-01
Primary completion
2022-06-09
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.